You need read it again. Stalmer clearly said the partial clinical hold is set for chronic administration. They need new pharmacological evidence for PBT2 as antibiotics as I have told you half a year before. Then they could be entitled to have a discussion with FDA. Hopefully more data will be reported in the coming months.
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $17.8K | 3.6M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 72800001 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 37260658 | 25 |
View Market Depth
| Last trade - 10.32am 27/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |